Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
MD
Diabetologist
MBBS, MPhil, Diploma in Diabetology
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S, F.C.P.S, F.P.S.I.M, C.H.P.E, M.A.C.G
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
Diabetologist
MBBS, MD (Internal Medicine), M.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures